PRDM13: PR/SET Domain 13 – Transcriptional Regulator in Retinal Development and Cancer

Comprehensive genomic and functional overview of PRDM13, a zinc finger transcription factor implicated in photoreceptor differentiation and tumorigenesis.

Gene Information Card

Symbol PRDM13
Full Name PR/SET Domain 13
Gene Type Protein coding
Chromosomal Location 6q16.1
NCBI Gene ID 59355 ncbi.nlm.nih.gov/gene/59355
Ensembl ID ENSG00000112237
UniProt ID Q9NQV5
OMIM ID 616741
HGNC ID 14001
Aliases PR domain containing 13, ZNF298, PFM10

Description

PRDM13 (PR/SET Domain 13) is a protein-coding gene located on chromosome 6q16.1. It encodes a zinc finger transcription factor containing an N-terminal PR domain (a SET-like domain) and multiple C2H2 zinc finger motifs. PRDM13 functions as a transcriptional repressor and plays a critical role in retinal development, particularly in the specification and differentiation of photoreceptor cells. It is also implicated in several cancers, including medulloblastoma and breast cancer, where altered expression or mutation may contribute to tumor progression.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Retinal dystrophy (cone-rod dystrophy) PRDM13 mutations disrupt photoreceptor differentiation, leading to progressive vision loss. ClinVar, OMIM #616741
Medulloblastoma PRDM13 is recurrently mutated in Group 4 medulloblastoma; loss of function may promote tumorigenesis. COSMIC, PubMed studies
Breast cancer PRDM13 overexpression correlates with poor prognosis; potential role in transcriptional dysregulation. NCBI Gene, literature

Expression Profile

Tissue Expression
Tissue nTPM level
Retina 12.5 High
Cerebellum 3.2 Low
Breast 1.8 Low
Testis 0.9 Not detected
Cell Line Expression
Cell Line nTPM Notes
ARPE-19 (retinal pigment epithelium) 4.1 Moderate expression
MCF7 (breast cancer) 6.7 Elevated compared to normal breast
DAOY (medulloblastoma) 2.3 Detectable
HEK293 (embryonic kidney) 0.5 Very low
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1012C>T (p.Arg338*) Nonsense <0.1% in general population Loss of function; truncation of zinc finger domain
c.1456G>A (p.Gly486Arg) Missense <0.01% Altered DNA-binding affinity
c.789_790insA (p.Glu264Argfs*12) Frameshift Somatic in medulloblastoma Loss of function
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations in PRDM13 lead to truncated proteins lacking functional zinc finger domains, impairing transcriptional repression activity.

Gain of Function (GOF)

No well-characterized gain-of-function mutations reported in PRDM13.

Dominant Negative (DN)

Some missense mutations may produce proteins that interfere with wild-type PRDM13 function, but dominant-negative effects are not firmly established.

Pathways

Retinal development and photoreceptor differentiation
Transcriptional regulation by PRDM family proteins
Medulloblastoma (Group 4) signaling

Protein Summary

PRDM13 is a 748-amino-acid nuclear protein containing an N-terminal PR domain (similar to SET methyltransferases) and six C2H2 zinc finger motifs. It acts primarily as a transcriptional repressor by recruiting chromatin-modifying complexes. In the retina, PRDM13 is essential for the proper specification of cone and rod photoreceptors. Its dysregulation is linked to retinal dystrophies and certain cancers, particularly Group 4 medulloblastoma.

Related Products

Product name Cat.No. Species Gene ID
PRDM13 Knockout HEK293 Cell Line EDJ-KQ14890 Human 59336 Details Get a Quote
PRDM13 Knockout HeLa Cell Line EDJ-KQ56966 Human 59336 Details Get a Quote
PRDM13 Knockout A-549 Cell Line EDJ-KQ65469 Human 59336 Details Get a Quote
PRDM13 Knockout HCT 116 Cell Line EDJ-KQ73907 Human 59336 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: